vs
Side-by-side financial comparison of Strive, Inc. (ASST) and Onconetix, Inc. (ONCO). Click either name above to swap in a different company.
Onconetix, Inc. is the larger business by last-quarter revenue ($303.6K vs $255.0K, roughly 1.2× Strive, Inc.). Onconetix, Inc. runs the higher net margin — 1867.5% vs -75406.7%, a 77274.2% gap on every dollar of revenue. On growth, Onconetix, Inc. posted the faster year-over-year revenue change (-57.4% vs -74.1%). Over the past eight quarters, Strive, Inc.'s revenue compounded faster (77.6% CAGR vs -34.2%).
Strive Asset Management is an American investment management firm founded in 2022. The firm operates mutual funds, exchange-traded products (ETPs), and wealth management services. Headquartered in Columbus, Ohio, it operates as a subsidiary of Strive Enterprises, Inc. and is registered with the U.S. Securities and Exchange Commission (SEC) as an investment adviser.
Onconetix, Inc. is a clinical-stage biopharmaceutical firm developing innovative targeted therapies for underserved cancer patients. Its pipeline includes candidates for hard-to-treat solid tumors, operating mainly across North American and global oncology markets, prioritizing treatments with superior safety and efficacy over existing standard care options.
ASST vs ONCO — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $255.0K | $303.6K |
| Net Profit | $-192.3M | $5.7M |
| Gross Margin | — | 81.6% |
| Operating Margin | -17288.6% | -422.1% |
| Net Margin | -75406.7% | 1867.5% |
| Revenue YoY | -74.1% | -57.4% |
| Net Profit YoY | -2726.9% | 119.3% |
| EPS (diluted) | $-0.22 | $-5.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $303.6K | ||
| Q3 25 | $255.0K | $303.7K | ||
| Q2 25 | $173.3K | $106.5K | ||
| Q1 25 | $170.7K | $101.6K | ||
| Q4 24 | $212.8K | $712.0K | ||
| Q3 24 | $984.0K | $406.9K | ||
| Q2 24 | $93.0K | $704.8K | ||
| Q1 24 | $124.8K | $700.4K |
| Q4 25 | — | $5.7M | ||
| Q3 25 | $-192.3M | $-8.8M | ||
| Q2 25 | $-8.9M | $-2.4M | ||
| Q1 25 | $-3.7M | $-8.5M | ||
| Q4 24 | $-4.1M | $-29.4M | ||
| Q3 24 | $-6.8M | $-3.8M | ||
| Q2 24 | $-5.9M | $-14.3M | ||
| Q1 24 | $-4.8M | $-11.1M |
| Q4 25 | — | 81.6% | ||
| Q3 25 | — | 88.6% | ||
| Q2 25 | — | 66.2% | ||
| Q1 25 | — | 45.1% | ||
| Q4 24 | — | 92.7% | ||
| Q3 24 | — | 25.9% | ||
| Q2 24 | — | 14.3% | ||
| Q1 24 | — | 27.0% |
| Q4 25 | — | -422.1% | ||
| Q3 25 | -17288.6% | -681.5% | ||
| Q2 25 | -1553.9% | -1817.4% | ||
| Q1 25 | -970.5% | -12369.2% | ||
| Q4 24 | -5889.5% | -4093.7% | ||
| Q3 24 | -712.4% | -650.3% | ||
| Q2 24 | -1857.2% | -1931.6% | ||
| Q1 24 | -1110.9% | -1582.2% |
| Q4 25 | — | 1867.5% | ||
| Q3 25 | -75406.7% | -2892.7% | ||
| Q2 25 | -5122.4% | -2227.8% | ||
| Q1 25 | -2195.6% | -8408.8% | ||
| Q4 24 | -1935.5% | -4134.7% | ||
| Q3 24 | -691.3% | -940.7% | ||
| Q2 24 | -6313.1% | -2029.8% | ||
| Q1 24 | -3837.7% | -1587.4% |
| Q4 25 | — | $-5.02 | ||
| Q3 25 | $-0.22 | $-6.25 | ||
| Q2 25 | $-0.17 | $-4.76 | ||
| Q1 25 | $-0.13 | $-0.53 | ||
| Q4 24 | $-5.62 | $637.36 | ||
| Q3 24 | $-3.06 | $-249.08 | ||
| Q2 24 | $-0.58 | $-2191.59 | ||
| Q1 24 | $-0.49 | $-20.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $109.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.4M | $15.8M |
| Total Assets | $792.6M | $24.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $109.1M | — | ||
| Q2 25 | $2.5M | — | ||
| Q1 25 | $4.2M | — | ||
| Q4 24 | $6.2M | — | ||
| Q3 24 | $2.1M | — | ||
| Q2 24 | $1.9M | — | ||
| Q1 24 | $1.9M | — |
| Q4 25 | — | $15.8M | ||
| Q3 25 | $779.4M | $3.4M | ||
| Q2 25 | $10.7M | $5.9M | ||
| Q1 25 | $19.6M | $4.0M | ||
| Q4 24 | $23.3M | $8.5M | ||
| Q3 24 | $27.5M | $33.9M | ||
| Q2 24 | $5.4M | $-35.8M | ||
| Q1 24 | $11.3M | $-21.5M |
| Q4 25 | — | $24.9M | ||
| Q3 25 | $792.6M | $19.7M | ||
| Q2 25 | $3.3M | $19.1M | ||
| Q1 25 | $5.0M | $18.8M | ||
| Q4 24 | $28.2M | $28.2M | ||
| Q3 24 | $2.6M | $61.9M | ||
| Q2 24 | $2.4M | $59.5M | ||
| Q1 24 | $2.1M | $75.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-14.0M | $-3.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | -0.55× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-3.1M | ||
| Q3 25 | $-14.0M | $-3.2M | ||
| Q2 25 | $-1.7M | $-1.4M | ||
| Q1 25 | $-1.6M | $-2.0M | ||
| Q4 24 | $-21.6M | $-917.6K | ||
| Q3 24 | $-13.2M | $-1.1M | ||
| Q2 24 | $-1.3M | $-3.2M | ||
| Q1 24 | $-1.0M | $-5.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-21.6M | $-921.5K | ||
| Q3 24 | $-13.4M | $-1.1M | ||
| Q2 24 | $-1.3M | $-3.2M | ||
| Q1 24 | $-1.1M | $-5.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -10161.2% | -129.4% | ||
| Q3 24 | -1360.3% | -282.4% | ||
| Q2 24 | -1379.4% | -456.4% | ||
| Q1 24 | -844.7% | -747.6% |
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 11.3% | 0.5% | ||
| Q3 24 | 18.8% | 0.6% | ||
| Q2 24 | 3.1% | 2.5% | ||
| Q1 24 | 9.5% | 0.7% |
| Q4 25 | — | -0.55× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
